Participants 153 182 4
patients with osteoarthritis.
Participants 348 381 3
patients with osteoarthritis (OA)
Participants 781 941 8
male and female patients (aged at least 40 years) with symptomatic primary OA of the hip, knee, hand or spine were randomised (1:2:1) to lumiracoxib 100 mg o.d.
Participants 2198 2214 3
patients with OA
